Universität Wien

322571 VU Technological and Biopharmaceutical Aspects of Biologics - M7/M14 (2024S)

1.00 ECTS (1.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Details

Language: English

Lecturers

Classes

Monday April 22th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Tuesday April 23th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Wednesday April 24th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Thursday April 25th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Friday April 26th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Thursday May 2rd, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Friday May 3rd, 2024 - 9:45 a.m. - 11:15 a.m. 2F161

Registration time frame: March 25th, 2024 to April 12th, 2024 inclusive
The number of participants is limited.

Information

Aims, contents and method of the course

This course will be taught using a mixture of lectures and tutorials (a total of 7 sessions).

Learning aims:
- Knowledge of formulation principles for biotech products
- Challenges of protein formulations (addressing challenges through preformulation)
- Knowledge of formulation processes and ingredients
- Knowledge of drug delivery mechanisms and kinetics
- Knowledge of parenteral controlled release formulations
- Knowledge of the basic concepts of Pharmacokinetics
- Overview on the pharmacokinetic models
- Knowledge concerning the relevant pharmacokinetic parameters
- Basics of the physiological background of the Pharmacokinetics
- Application of the pharmacokinetic evaluation on selected drugs

Assessment and permitted materials

Shelf life prediction calculation exercise (50% of total mark)
Pharmacokinetics calculation exercise (50% of total mark)

Minimum requirements and assessment criteria

A minimum of total of 50% in each of the assessment exersices will be necessary to pass this course.

Examination topics

Reading list

Wang & Ohtake, Science and art of protein formulation development. International Journal of Pharmaceutics (2019) 568:118505
https://doi.org/10.1016/j.ijpharm.2019.118505

Anselmo, Gokarn & Mitragotri, Non-invasive delivery strategies for biologics. Nature Reviews Drug Discovery (2019) 18:19–40
https://doi.org/10.1038/nrd.2018.183

Rugo et al., Demystifying biosimilars: development, regulation and clinical use. Future Oncology (2019) 15
https://doi.org/10.2217/fon-2018-0680

Association in the course directory

MA8, MA23

Last modified: We 10.04.2024 13:46